Intelligence · Drug directory
EMA-Approved Drugs Directory
European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
Quick answer
EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
-
vardenafil
LEVITRA
G04BE09 -
velmanase alfa
LAMZEDE
A16AB15 -
vernakalant hydrochloride
BRINAVESS
C01BG11 -
vildagliptin
GALVUS Novartis Pharmaceuticals
A10BH02 -
vilobelimab
GOHIBIC
L04AJ10 -
vinflunine
JAVLOR
L01CA05 -
volanesorsen
WAYLIVRA
C10AX18 -
vonicog alfa
VEYVONDI
B02BD10 -
voretigene neparvovec
LUXTURNA
S01XA27 -
vysribli
VYSRIBLI (PREVIOUSLY DENOSUMAB INTAS)
M05BX04 -
yttrium [90y] chloride
YTTRIGA
V09 -
zapomeran
KOSTAIVE
J07BN01 -
ziconotide
PRIALT
N02BG08 -
zilucoplan
ZILBRYSQ
L04AJ06 -
zinc
NULL
A16AX05 -
zolbetuximab
VYLOY
L01FX31 -
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)
AFLUNOV
J07BB02 -
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
CELLDEMIC
J07BB02 -
zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)
ZOONOTIC INFLUENZA VACCINE SEQIRUS
J07BB02
Frequently asked questions
How many ema approved drugs are listed?
931 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.